共 50 条
- [1] THE RELATIONSHIP AMONG ADVERSE DRUG REACTION REPORTING, DRUG LABELING, PRODUCT LIABILITY, AND FEDERAL PREEMPTION [J]. FOOD AND DRUG LAW JOURNAL, 1991, 46 (01): : 31 - 42
- [2] REPORTING OF ADVERSE DRUG-REACTIONS AND PHYSICIAN LIABILITY [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (03): : 538 - &
- [3] Reporting Adverse Drug Reactions in Product Labels [J]. Therapeutic Innovation & Regulatory Science, 2016, 50 : 455 - 463
- [5] A REVIEW OF POSTMARKETING ADVERSE DRUG EXPERIENCE REPORTING REQUIREMENTS [J]. FOOD AND DRUG LAW JOURNAL, 1991, 46 (05): : 665 - 672
- [8] Adverse drug reactions reporting in the UK: 50 years of experience [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (12): : 1679 - 1679
- [9] LIABILITY AND DRUG PRODUCT SELECTION [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1977, 17 (05): : 273 - 273